Figure 2 | Scientific Reports

Figure 2

From: Mortality outcomes in diabetic metabolic dysfunction-associated fatty liver disease: non-obese versus obese individuals

Figure 2

(a–c) Cumulative incidence of all-cause death, cardiovascular death, cancer death with different subtypes of MAFLD. Outcomes for (a) all-cause death, (b) cardiovascular death, and (c) cancer death. (d) Correlation between different subtypes of MAFLD and all-cause, cardiovascular-related, and cancer-related mortalities, using LM group as a reference (value of 1.00). Outcomes after adjusting for aspartate amino-transferase/alanine aminotransferase, triglyceride, blood urea nitrogen, lactate dehydrogenase, blood creatinine, C-reactive protein, and hypertension.

Back to article page